These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Interleukin 12/interleukin 23 pathway: Biological basis and therapeutic effect in patients with Crohn's disease. Aggeletopoulou I; Assimakopoulos SF; Konstantakis C; Triantos C World J Gastroenterol; 2018 Sep; 24(36):4093-4103. PubMed ID: 30271076 [TBL] [Abstract][Full Text] [Related]
30. Controversial Contribution of Th17/IL-17 Toward the Immune Response in Intestinal Fibrosis. Latella G; Viscido A Dig Dis Sci; 2020 May; 65(5):1299-1306. PubMed ID: 32124197 [TBL] [Abstract][Full Text] [Related]
31. Targeting the development and effector functions of TH17 cells. Ghilardi N; Ouyang W Semin Immunol; 2007 Dec; 19(6):383-93. PubMed ID: 18083530 [TBL] [Abstract][Full Text] [Related]
32. Increased prevalence of circulating novel IL-17 secreting Foxp3 expressing CD4+ T cells and defective suppressive function of circulating Foxp3+ regulatory cells support plasticity between Th17 and regulatory T cells in inflammatory bowel disease patients. Ueno A; Jijon H; Chan R; Ford K; Hirota C; Kaplan GG; Beck PL; Iacucci M; Fort Gasia M; Barkema HW; Panaccione R; Ghosh S Inflamm Bowel Dis; 2013 Nov; 19(12):2522-34. PubMed ID: 24097227 [TBL] [Abstract][Full Text] [Related]
33. Costimulation of Th17 cells: Adding fuel or putting out the fire in the inflamed gut? Zhang Z; Rosenbaum JT; Zhong W; Lim C; Hinrichs DJ Semin Immunopathol; 2010 Mar; 32(1):55-70. PubMed ID: 20119686 [TBL] [Abstract][Full Text] [Related]
34. Crossover Subsets of CD4 Li J; Ueno A; Iacucci M; Fort Gasia M; Jijon HB; Panaccione R; Kaplan GG; Beck PL; Luider J; Barkema HW; Qian J; Gui X; Ghosh S Dig Dis Sci; 2017 Sep; 62(9):2357-2368. PubMed ID: 28573508 [TBL] [Abstract][Full Text] [Related]
36. Interleukin-25 inhibits interleukin-12 production and Th1 cell-driven inflammation in the gut. Caruso R; Sarra M; Stolfi C; Rizzo A; Fina D; Fantini MC; Pallone F; MacDonald TT; Monteleone G Gastroenterology; 2009 Jun; 136(7):2270-9. PubMed ID: 19505427 [TBL] [Abstract][Full Text] [Related]
37. Interleukin-21 (IL-21) controls inflammatory pathways in the gut. Fina D; Caruso R; Pallone F; Monteleone G Endocr Metab Immune Disord Drug Targets; 2007 Dec; 7(4):288-91. PubMed ID: 18220949 [TBL] [Abstract][Full Text] [Related]
38. Role of the IL-23/IL-17 axis in Crohn's disease. Siakavellas SI; Bamias G Discov Med; 2012 Oct; 14(77):253-62. PubMed ID: 23114581 [TBL] [Abstract][Full Text] [Related]